// App-Quantinova.ai

AB0554 (2022) : CLINICAL CHARACTERISTICS AND BURDEN AMONG PATIENTS WITH SLE STRATIFIED BY SLEDAI DERIVED SEVERITY: RESULTS FROM A REAL-WORLD STUDY IN THE US

Researchers

Presenter

  • A. Vadhariya

Principal Investigators

  • J. Birt

  • J. Wu

  • K. Griffing

  • F. Bailey

  • J. Hetherington

  • E. Rottier

  • S. Barlow

  • K. Costenbader

Medical Centers

  • Eli Lilly and Company, Indianapolis, United States of America

  • Adelphi Real World, Bollington, United Kingdom

  • Brigham and Women’s Hospital, Harvard Medical School, Division of Rheumatology, Immunology and Allergy, Boston, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Exagen Inc.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved